Fabry Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Enzyme Replacement Therapy (ERT), Substrate Reduction Therapy (SRT), Chaperone Treatment), By Region, And Segment Forecasts, 2019 - 2025

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Region-wise Market Calculation
1.4.1 Region-Wise Market: Base Estimates
1.4.2 Global Market: CAGR Calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
1.7 List of Primary Sources
1.7.1 Primary interview breakup
1.7.1.1 Data for primary interviews, by sources
1.7.1.2 Data for primary interviews, by region
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Fabry Disease Treatment Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by treatment
3.4.2 Key opportunities prioritized, by region
3.5 Fabry Disease - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.6 Industry Analysis - Porter’s
3.7 Fabry Disease: Market Position Analysis, 2017
Chapter 4 Fabry Disease Treatment Market: Treatment Analysis
4.1 Treatment Business Analysis
4.2 Fabry Disease Treatment Market: Treatment Movement Analysis
4.2.1 Enzyme Replacement Therapy (ERT)
4.2.1.1酶替代疗法(ERT)市场timates and forecasts, 2016 - 2025 (USD Million)
4.2.2 Chaperone Treatment
4.2.2.1 Chaperone Treatment market estimates and forecasts, 2016 - 2025 (USD Million)
4.2.3 Substrate Reduction Therapy (SRT)
4.2.3.1 Substrate Reduction Therapy (SRT) market estimates and forecasts, 2016 - 2025 (USD Million)
4.2.4 Others
4.2.4.1 Others market estimates and forecasts, 2016 - 2025 (USD Million)
Chapter 5 Fabry Disease Treatment Market: Regional Estimates & Trend Analysis, by Treatment
5.1 Fabry Disease Treatment Market Share by Region, 2017 & 2025
5.2 North America
5.2.1 North America
5.2.1.1 North America Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe
5.3.1.1 Europe Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.3.2 Germany
5.3.2.1 Germany Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.3.3 U.K.
5.3.3.1 U.K. Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific
5.4.1.1 Asia Pacific Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.4.2 Japan
5.4.2.1 Japan Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.4.3 China
5.4.3.1 China Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.4.4 India
5.4.4.1 India Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.5 Latin America
5.5.1 Latin America
5.5.1.1 Latin America Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.6 MEA
5.6.1 MEA
5.6.1.1 MEA Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 Sanofi S.A.
6.1.1.1 Company Overview
6.1.1.2 Financial Performance
6.1.1.3 Product Benchmarking
6.1.1.4 Strategic Initiatives
6.1.2 Shire Plc.
6.1.2.1 Company Overview
6.1.2.2 Financial Performance
6.1.2.3 Product Benchmarking
6.1.2.4 Strategic Initiatives
6.1.3 Amicus Therapeutics Inc.
6.1.3.1 Company Overview
6.1.3.2 Financial Performance
6.1.3.3 Product Benchmarking
6.1.3.4 Strategic Initiatives
6.1.4 ISU Abxis Co Ltd.
6.1.4.1 Company Overview
6.1.4.2 Financial Performance
6.1.4.3 Product Benchmarking
6.1.4.4 Strategic Initiatives
6.1.5 JCR Pharmaceuticals Co Ltd.
6.1.5.1 Company Overview
6.1.5.2 Financial Performance
6.1.5.3 Strategic Initiatives
6.1.6 Protalix Biotherapeutics Inc.
6.1.6.1 Company Overview
6.1.6.2 Financial Performance
6.1.6.3 Strategic Initiatives
6.1.7 Idorsia Pharmaceuticals Ltd.
6.1.7.1 Company Overview
6.1.7.2 Financial Performance
6.1.7.3 Strategic Initiatives
6.1.8 Avrobio Inc.
6.1.8.1 Company Overview
6.1.8.2 Financial Performance
6.1.8.3 Strategic Initiatives

List of Tables

Table 1 Global Fabry Disease Treatment Market, by country, 2016 - 2025 (USD Million)
表2全球Fabry疾病治疗市场treatment, 2016 - 2025 (USD Million)
表3北美Fabry疾病治疗et, by country, 2016 - 2025 (USD Million)
Table 4 North America Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 5 U.S. Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 6 Canada Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 7 Europe Fabry Disease Treatment Market, by country, 2016 - 2025 (USD Million)
Table 8 Europe Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 9 U.K. Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 10 Germany Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 11 Asia Pacific Fabry Disease Treatment Market, by country, 2016 - 2025 (USD Million)
Table 12 Asia Pacific Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 13 Japan Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 14 China Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 15 India Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 16 Latin America Fabry Disease Treatment Market, by country, 2016 - 2025 (USD Million)
Table 17 Latin America Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 18 Brazil Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 19 Mexico Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 20 MEA Fabry Disease Treatment Market, by country, 2016 - 2025 (USD Million)
Table 21 MEA Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)
Table 22 South Africa Fabry Disease Treatment Market, by treatment, 2016 - 2025 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Primary interviews, by sources
Fig. 9 Primary interviews, by region
Fig. 10 Fabry Disease Treatment Market summary
Fig. 11 Fabry Disease Treatment Market trends and outlook
Fig. 12 Fabry Disease Treatment Market segmentation
Fig. 13 Fabry Disease Treatment Market driver impact
Fig. 14 Fabry Disease Treatment Market restraint impact
Fig. 15 Key opportunities prioritized, Treatment
Fig. 16 Key opportunities prioritized, Region
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Porter’s five forces analysis
Fig. 19 Fabry disease outlook: Key takeaways
Fig. 20 Fabry Disease Treatment Market: Treatment analysis
Fig. 21 Enzyme Replacement Therapy (ERT) market, 2016 - 2025 (USD Million)
Fig. 22 Chaperone Treatment market, 2016 - 2025 (USD Million)
Fig. 23 Substrate Reduction Therapy (SRT) market, 2016 - 2025 (USD Million)
Fig. 24 Others market, 2016 - 2025 (USD Million)
Fig. 25 Regional market place: Key takeaways
Fig. 26 Regional outlook, 2017 & 2025